Motif Bio Competitors and Similar CompaniesClear all
Motif Bio's competitors and similar companies include NIOX, Durect and Array BioPharma.
 Motif Bio Motif BioSciences, a population genetics company, focuses on the genetic causes of major diseases usinghuman genetic data from individuals. |  NIOX NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies |  Durect DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases. |  Array BioPharma Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. | |
Founding Date | Founding Date N/A | Founding Date 2006 | Founding Date N/A | Founding Date 1998 |
Type | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations London, GB HQ New York, US | Locations Morrisville, US HQ Bad Homburg Vor Der Höhe, DE Uppsala, SE Morrisville, US | Locations Cupertino, US HQ | Locations Boulder, US HQ Chicago, US Detroit, US Houston, US Miami, US New York, US Phoenix, US |
Employees | Employees 6 | Employees 91 | Employees 902% increase | Employees 110 |
Valuation ($) | Valuation ($) 4.6 m | Valuation ($) 340.9 m | Valuation ($) 45.3 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) £48.7m (FY, 2025) | Revenue (est.) $2m (FY, 2024) | Revenue (est.) $173.8m (FY, 2018) |
Cost of goods | Cost of goods N/A | Cost of goods £11.1m (FY, 2025) | Cost of goods $78k (FY, 2024) | Cost of goods $59.4m (FY, 2018) |
Gross profit | Gross profit N/A | Gross profit £38.2m (FY, 2025) | Gross profit $2m (FY, 2024) | Gross profit $114.4m (FY, 2018) |
Net income | Net income (£10.7m) (FY, 2018) | Net income £7m (FY, 2025) | Net income ($8.3m) (FY, 2024) | Net income ($147.7m) (FY, 2018) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 122.8m | Total funding raised $ 20m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
NIOX
HQ
Morrisville, US
Employees
91
NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies
View companyDurect
HQ
Cupertino, US
Employees
90↑ 2% increase
DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases.
View companyArray BioPharma
HQ
Boulder, US
Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
View company